495 related articles for article (PubMed ID: 8364280)
1. Controversies in the management of Mycobacterium avium complex infection in AIDS patients.
Peloquin CA
Ann Pharmacother; 1993; 27(7-8):928-37. PubMed ID: 8364280
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes.
Peloquin CA
Clin Pharmacokinet; 1997 Feb; 32(2):132-44. PubMed ID: 9068928
[TBL] [Abstract][Full Text] [Related]
3. Current and investigational therapies for AIDS-associated Mycobacterium avium complex disease.
Rathbun RC; Martin ES; Eaton VE; Matthew EB
Clin Pharm; 1991 Apr; 10(4):280-91. PubMed ID: 2032445
[TBL] [Abstract][Full Text] [Related]
4. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
Wright J
Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
[TBL] [Abstract][Full Text] [Related]
5. New trends in the drug therapy of localized and disseminated Mycobacterium avium complex infection.
Sesin GP; Manzi SF; Pacheco R
Am J Health Syst Pharm; 1996 Nov; 53(21):2585-90. PubMed ID: 8913387
[TBL] [Abstract][Full Text] [Related]
6. Infection caused by Mycobacterium tuberculosis.
Peloquin CA; Berning SE
Ann Pharmacother; 1994 Jan; 28(1):72-84. PubMed ID: 8123968
[TBL] [Abstract][Full Text] [Related]
7. Risk-benefit assessment of therapies for Mycobacterium avium complex infections.
Griffith DE
Drug Saf; 1999 Aug; 21(2):137-52. PubMed ID: 10456381
[TBL] [Abstract][Full Text] [Related]
8. Treatment and prophylaxis of disseminated Mycobacterium avium complex in HIV-infected individuals.
Faris MA; Raasch RH; Hopfer RL; Butts JD
Ann Pharmacother; 1998 May; 32(5):564-73. PubMed ID: 9606478
[TBL] [Abstract][Full Text] [Related]
9. Clarithromycin prophylaxis against disseminated Mycobacterium avium complex in patients with AIDS.
Archange YR; Carrey Z; Zanlungo PG
J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):20-2. PubMed ID: 11362747
[TBL] [Abstract][Full Text] [Related]
10. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Cohn DL
Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
[TBL] [Abstract][Full Text] [Related]
11. Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy.
Heifets LB
Res Microbiol; 1994; 145(3):188-96. PubMed ID: 7809471
[No Abstract] [Full Text] [Related]
12. The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections.
Amsden GW; Peloquin CA; Berning SE
Drugs; 1997 Jul; 54(1):69-80. PubMed ID: 9211081
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
Ramirez J; Mason C; Ali J; Lopez FA
J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
[TBL] [Abstract][Full Text] [Related]
14. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
15. A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes.
Aoki A; Jinno H; Ogawa K; Nakagawa T; Inagaki T; Wajima T; Okamoto Y; Uchiya KI
Microbiol Spectr; 2023 Feb; 11(1):e0432622. PubMed ID: 36622171
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium avium complex-associated cholecystitis in AIDS patient: a case description and review of literature.
El Chaer F; Harris N; El Sahly H; Hemmige V; Martinez Blanco E; Woc-Colburn L
Int J STD AIDS; 2016 Nov; 27(13):1218-1222. PubMed ID: 26023092
[TBL] [Abstract][Full Text] [Related]
17. Present status and future prospects of chemotherapeutics for intractable infections due to Mycobacterium avium complex.
Tomioka H
Curr Drug Discov Technol; 2004 Dec; 1(4):255-68. PubMed ID: 16472242
[TBL] [Abstract][Full Text] [Related]
18. Treatment of nontuberculous mycobacterial infections in pediatric patients.
Levin RH; Bolinger AM
Clin Pharm; 1988 Jul; 7(7):545-51. PubMed ID: 2843317
[TBL] [Abstract][Full Text] [Related]
19. Treatment and prophylaxis of Mycobacterium avium complex.
Young LS
Int J STD AIDS; 1996; 7 Suppl 1():23-7. PubMed ID: 8652724
[TBL] [Abstract][Full Text] [Related]
20. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
Kadota T; Matsui H; Hirose T; Suzuki J; Saito M; Akaba T; Kobayashi K; Akashi S; Kawashima M; Tamura A; Nagai H; Akagawa S; Kobayashi N; Ohta K
BMC Infect Dis; 2016 Jan; 16():31. PubMed ID: 26818764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
